butyl-heptyl ether | 71112-90-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: butyl-heptyl ether
• 英文别名: Butyl-heptyl-aether；n-Butyl-n-heptyl-aether；1-butoxy-heptane；Heptoxybutan；1-butoxyheptane
• CAS: 71112-90-8
• 化学式: C₁₁H₂₄O
• 分子量: 172.311
• InChiKey: VECXYESVGQSDMX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  12
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS
  申请人：Koenemann Martin

  公开号：US20100048904A1

  公开（公告）日：2010-02-25

  Dibenzorylenetetracarboximides of the general formula I in which the variables are each defined as follows: R′ are identical or different radicals: hydrogen; optionally substituted aryloxy, arylthio, hetaryloxy or hetarylthio; R are identical or different radicals: hydrogen; optionally substituted C 1 -C 30 -alkyl, C 3 -C 8 -cycloalkyl, aryl or hetaryl; m, n are each independently 0 or 1.

  一般式I的二苯并咔唑四羧酰亚胺中，变量定义如下：R′为相同或不同的基团：氢；可选择取代的芳氧基、芳硫基、杂芳氧基或杂芳硫基；R为相同或不同的基团：氢；可选择取代的C1-C30烷基、C3-C8环烷基、芳基或杂芳基；m，n各自独立地为0或1。
• LIQUID CRYSTALLINE RYLENE TETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF
  申请人：Koenemann Martin

  公开号：US20110042651A1

  公开（公告）日：2011-02-24

  The present invention relates to liquid-crystalline rylenetetracarboxylic acid derivatives, to processes for their preparation and to their use as n-type organic semiconductors for producing organic field-effect transistors and solar cells.

  本发明涉及液晶芳纶四羧酸衍生物，其制备方法以及作为n型有机半导体用于制造有机场效应晶体管和太阳能电池的用途。
• PROCESS FOR PRODUCTION OF 4-(SUBSTITUTED PHENYL)HEXAHYDROPYRIDOÝ2,1-C¨Ý1,4¨OXAZIN-6-ONE
  申请人：Eisai R&D Management Co., Ltd.

  公开号：EP2226325A1

  公开（公告）日：2010-09-08

  4-(Substituted phenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-one represented by formula (I) or a salt thereof is useful as an intermediate for the production of a bicyclic cinnamide compound which is an Aβ production inhibitor. 4-(Substituted phenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-one or the salt thereof can be produced in an industrially advantageous manner by subjecting a compound represented by formula (II) or a salt thereof to an intramolecular condensation reaction.

  公式(I)表示的4-(取代苯基)六氢吡啶并[2,1-c][1,4]噁唑啉-6-酮或其盐可用作生产双环丁酰胺化合物的中间体，该化合物是Aβ产生抑制剂。通过将公式(II)表示的化合物或其盐经历分子内缩合反应，可以以工业上有利的方式生产4-(取代苯基)六氢吡啶并[2,1-c][1,4]噁唑啉-6-酮或其盐。
• [EN] OLIGOCONDENSED PERYLENE BISIMIDES<br/>[FR] BISIMIDES DE PÉRYLÈNE OLIGOCONDENSÉS
  申请人：BASF SE

  公开号：WO2010111822A1

  公开（公告）日：2010-10-07

  The present invention relates to oligocondensed perylene bisimides, a method for their production and their use.

  本发明涉及寡聚化的苝二酰亚胺，其生产方法及其用途。
• COMPOUNDS EXHIBITING THROMBOPOIETIN RECEPTOR AGONISM
  申请人：Takayama Masami

  公开号：US20090318513A1

  公开（公告）日：2009-12-24

  A compound represented by the general formula (I): wherein R 1 is a hydrogen atom, a halogen atom, or the like; R 2 , R 3 , and R 4 are each independently a hydrogen atom, a halogen atom, C1-C15 alkyl optionally substituted with one or more C1-C12 alkyloxy or the like, or the like; R 5 is a hydrogen atom or the like; R 6 and R 7 are a hydrogen atom or the like; R 8 is C1-C3 alkyl or the like; R 9 is a hydrogen atom or the like), a prodrug, a pharmaceutically acceptable salt, or solvate thereof.

  一种由通式（I）表示的化合物：其中R1是氢原子、卤素原子或类似物；R2、R3和R4各自独立地是氢原子、卤素原子、C1-C15烷基（可选地用一个或多个C1-C12烷氧基或类似物取代）或类似物；R5是氢原子或类似物；R6和R7是氢原子或类似物；R8是C1-C3烷基或类似物；R9是氢原子或类似物。该化合物为一种前药、药物可接受的盐或其溶剂。